A synthetic targeted RNA demethylation system based on CRISPR‐Cas13b inhibits bladder cancer progression
Main Authors: | Ganglin Su, Lin Yao, Xiaohong Han, Xinhui Liao, Jieqing Chen, Tao Yin, Ying Dong, Yanfeng Li, Kun Hu, Junwen Xiao, Yuchen Liu, Weiren Huang, Hongbing Mei |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-02-01
|
Series: | Clinical and Translational Medicine |
Online Access: | https://doi.org/10.1002/ctm2.734 |
Similar Items
-
CRISPR-Cas13-Mediated Knockdown of lncRNA-GACAT3 Inhibited Cell Proliferation and Motility, and Induced Apoptosis by Increasing p21, Bax, and E-Cadherin Expression in Bladder Cancer
by: Zhongfu Zhang, et al.
Published: (2021-01-01) -
YTHDF2 is a Potential Biomarker and Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma
by: Ganglin Su, et al.
Published: (2021-08-01) -
Targeted Methylation of the LncRNA NEAT1 Suppresses Malignancy of Renal Cell Carcinoma
by: Jieqing Chen, et al.
Published: (2021-12-01) -
Engineered CRISPR/Cas13d Sensing hTERT Selectively Inhibits the Progression of Bladder Cancer In Vitro
by: Chengle Zhuang, et al.
Published: (2021-03-01) -
RNA targeting with CRISPR–Cas13
by: Essletzbichler, Patrick, et al.
Published: (2018)